Advancements in Concussion Testing and Merck's Innovations in Healthcare

This chapter explores a new rapid blood test by Avid Labs designed to objectively diagnose concussions in young athletes, emphasizing the need for safety in contact sports. It also examines Merck's current challenges, particularly with patent expirations, while showcasing the significance of their drug pipeline and advancements in cancer treatment.